Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma
- PMID: 28395901
- PMCID: PMC5521256
- DOI: 10.1016/j.jtcvs.2017.02.061
Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma
Abstract
Objective: Soft-tissue sarcoma is a heterogeneous disease that frequently includes the development of pulmonary metastases. The purpose of this study is to determine factors associated with improved survival among patients with soft-tissue sarcoma to help guide selection for pulmonary metastasectomy.
Methods: We reviewed a prospectively maintained database and identified 803 patients who underwent pulmonary metastasectomy for metastatic soft-tissue sarcoma between September 1991 and June 2014; of these, 539 patients undergoing 760 therapeutic-intent pulmonary metastasectomies were included. Clinicopathologic variables and characteristics of treatment were examined. The outcomes of interest were overall survival and disease-free survival. Survival was estimated with the Kaplan-Meier method and compared between variables with the log-rank test. Factors associated with hazard of death and recurrence were identified via the use of univariable and multivariable Cox proportional hazards models.
Results: Median overall survival was 33.2 months (95% confidence interval, 29.9-37.1), and median disease-free survival was 6.8 months (95% confidence interval, 6.0-8.0). In multivariable analyses, leiomyosarcoma histologic subtype (P = .007), primary tumor size ≤10 cm (P = .006), increasing time from primary tumor resection to development of metastases (P < .001), solitary lung metastasis (P = .001), and minimally invasive resection (P = .023) were associated with lower hazard of death. Disease-free interval ≥1 year (P = .002), and 1 pulmonary metastasis (P < .001) were associated with lower hazard of disease recurrence.
Conclusions: In a large single-institution study, primary tumor histologic subtype and size, numbers of pulmonary metastases, disease-free interval, and selection for minimally invasive resection are associated with increased survival in patients undergoing pulmonary metastasectomy for soft-tissue sarcoma.
Keywords: lung cancer surgery; metastases; metastatic soft-tissue sarcoma; pulmonary metastasectomy; soft-tissue sarcoma.
Copyright © 2017 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
Comment in
-
Resection of pulmonary sarcomatous metastases: Cut to cure?J Thorac Cardiovasc Surg. 2017 Jul;154(1):331. doi: 10.1016/j.jtcvs.2017.03.011. Epub 2017 Mar 9. J Thorac Cardiovasc Surg. 2017. PMID: 28359577 No abstract available.
-
Discussion.J Thorac Cardiovasc Surg. 2017 Jul;154(1):329-330. doi: 10.1016/j.jtcvs.2017.02.062. Epub 2017 Apr 8. J Thorac Cardiovasc Surg. 2017. PMID: 28395902 No abstract available.
-
Evidence for resection of sarcoma pulmonary metastases: More, but better?J Thorac Cardiovasc Surg. 2017 Jul;154(1):317-318. doi: 10.1016/j.jtcvs.2017.03.132. Epub 2017 Apr 7. J Thorac Cardiovasc Surg. 2017. PMID: 28511805 No abstract available.
Similar articles
-
Long-term outcomes and prognostic factors of pulmonary metastasectomy for osteosarcoma and soft tissue sarcoma.Int J Clin Oncol. 2019 Jul;24(7):863-870. doi: 10.1007/s10147-019-01422-0. Epub 2019 Feb 26. Int J Clin Oncol. 2019. PMID: 30806840
-
Survival following Pulmonary Metastasectomy for Sarcoma.Thorac Cardiovasc Surg. 2016 Mar;64(2):146-9. doi: 10.1055/s-0035-1546430. Epub 2015 Mar 5. Thorac Cardiovasc Surg. 2016. PMID: 25742552
-
Pulmonary metastasectomy: analysis of survival and prognostic factors in 243 patients.ANZ J Surg. 2018 Dec;88(12):1316-1321. doi: 10.1111/ans.14811. Epub 2018 Sep 13. ANZ J Surg. 2018. PMID: 30211472
-
[Pulmonary metastasectomy for osteosarcomas and soft tissue sarcomas].Gan To Kagaku Ryoho. 2004 Sep;31(9):1319-23. Gan To Kagaku Ryoho. 2004. PMID: 15446550 Review. Japanese.
-
Surgical treatment of metastatic pulmonary soft-tissue sarcoma.Oncology (Williston Park). 2000 Jun;14(6):835-41; discussion 842-4, 847. Oncology (Williston Park). 2000. PMID: 10887634 Review.
Cited by
-
Stereotactic ablative brachytherapy with or without assistance of 3D-printing templates for inoperable locally recurrent or oligometastatic soft-tissue sarcoma: a multicenter real-world study.Am J Cancer Res. 2023 Dec 15;13(12):6226-6240. eCollection 2023. Am J Cancer Res. 2023. PMID: 38187073 Free PMC article.
-
Clinical Outcome in Soft Tissue Sarcoma Patients with Lung Metastasis Who Received Metastasectomy and/or Radiofrequency Ablation: Tokai Musculoskeletal Oncology Consortium Study.Cancer Manag Res. 2021 Nov 10;13:8473-8480. doi: 10.2147/CMAR.S333721. eCollection 2021. Cancer Manag Res. 2021. PMID: 34785953 Free PMC article.
-
Reply from author: What is the right answer for pulmonary metastatic disease? More clinical trials.JTCVS Open. 2021 Sep 16;8:616-617. doi: 10.1016/j.xjon.2021.09.015. eCollection 2021 Dec. JTCVS Open. 2021. PMID: 36004101 Free PMC article. No abstract available.
-
Near-infrared intraoperative imaging for minimally invasive pulmonary metastasectomy for sarcomas.J Thorac Cardiovasc Surg. 2019 May;157(5):2061-2069. doi: 10.1016/j.jtcvs.2018.10.169. Epub 2018 Dec 14. J Thorac Cardiovasc Surg. 2019. PMID: 31288365 Free PMC article. Clinical Trial.
-
Pulmonary metastasectomy in bone and soft tissue sarcoma with metastasis to the lung.Interact Cardiovasc Thorac Surg. 2021 Nov 22;33(6):879-884. doi: 10.1093/icvts/ivab178. Interact Cardiovasc Thorac Surg. 2021. PMID: 34516633 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29. - PubMed
-
- Coindre JM, Terrier P, Guillou L, Le Doussal V, Collin F, Ranchere D, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer. Cancer. 2001;91:1914–26. - PubMed
-
- Smith R, Demmy TL. Pulmonary metastasectomy for soft tissue sarcoma. Surg Oncol Clin N Am. 2012;21:269–86. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical